Real-life outcomes of intravitreal ranibizumab, aflibercept, and dexamethasone implant administrations in patients with treatment-naïve diabetic macular edema

PURPOSE: To investigate optical coherence tomography (OCT) biomarker data on visual recovery in treatment-naïve diabetic macular edema (DME) and follow the results of intravitreal ranibizumab (RNB), aflibercept (AFL), and dexamethasone (DEX) implant administration within the 1(st) year of the pro re...

Descripción completa

Detalles Bibliográficos
Autores principales: Korkmaz, Anil, Karti, Omer, Zengin, Mehmet O., Yuksel, Bora, Kusbeci, Tuncay
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wolters Kluwer - Medknow 2021
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583353/
https://www.ncbi.nlm.nih.gov/pubmed/36276250
http://dx.doi.org/10.4103/sjopt.sjopt_59_21

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9583353/
https://www.ncbi.nlm.nih.gov/pubmed/36276250
http://dx.doi.org/10.4103/sjopt.sjopt_59_21

Ejemplares similares